(Z)-7-((1R,2R,5S)-5-Hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)-3-oxocyclopentyl)hept-5-enoic acid

Catalog No. :
ACWLWX579
CAS No. :
85280-91-7
Molecular Formula :
C23H30O5
Molecular Weight :
386.49

IUPAC Name:(Z)-7-((1R,2R,5S)-5-hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)-3-oxocyclopentyl)hept-5-enoic acid

(Z)-7-((1R,2R,5S)-5-Hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)-3-oxocyclopentyl)hept-5-enoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Z)-7-((1R,2R,5S)-5-Hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)-3-oxocyclopentyl)hept-5-enoic acid
IUPAC Name(Z)-7-((1R,2R,5S)-5-hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)-3-oxocyclopentyl)hept-5-enoic acid
Molecular FormulaC23H30O5
Molecular Weight386.49
SMILESO=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCC2=CC=CC=C2)C(C[C@@H]1O)=O
InChI KeyOAQGPAZDRCBBLD-YTCWWFNZSA-N
Synonym(Z)-7-[(1R)-5α-Hydroxy-2β-[(E,S)-3-hydroxy-5-phenyl-1-pentenyl]-3-oxocyclopentan-1α-yl]-5-heptenoic acid;17-Phenyl-18,19,20-trinor-PGD2;17-phenyl-18,19,20-trinor-prostaglandin D2;OAQGPAZDRCBBLD-YTCWWFNZSA-N;5-Heptenoic acid, 7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-3-oxocyclopentyl]-, (5Z)-;7-(5-Hydroxy-2-(3-hydroxy-5-phenyl-1-octenyl)-3-oxocyclopentyl)-5-heptenoic acid
CAS No.85280-91-7

Synthetic Route by SureRoute

1. ACWLWX579 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWLWX579 route product structure diagram
    ACWLWX57985280-91-7
Inquiry

2. ACWLWX579 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWLWX579 route product structure diagram
    ACWLWX57985280-91-7
Inquiry

Comments (0)